Medicare Enrolled
Dr. David Yin
Hematology & Oncology · Mesquite, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yin
Dr. David Yin is a hematology & oncology specialist in Mesquite, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Yin performed 27,233 Medicare services across 840 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yin received a total of $2,494 from 38 pharmaceutical and/or device companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 30% volume in TX
$2,494 industry payments
Medicare Practice Summary
Medicare Utilization ↗27,233
Medicare services
Top 30% in TX for hematology & oncology
840
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,026 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
9,000 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
7,975 | $2 | $20 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,801 | $0 | $3 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
3,450 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
730 | $0 | $1 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
339 | $13 | $43 |
| Anti-nausea injection (Aloxi/palonosetron) | 260 | $1 | $114 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
168 | $10 | $64 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
165 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
150 | $8 | $36 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $97 | $368 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
109 | $12 | $108 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
106 | $291 | $2,762 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
91 | $11 | $96 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
84 | $104 | $707 |
| Radiation therapy, 3+ areas, 11-19 MeV Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators. |
63 | $190 | $700 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
56 | $51 | $313 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
50 | $16 | $100 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
48 | $13 | $60 |
| Iron level test | 48 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
48 | $9 | $35 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
38 | $54 | $821 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
38 | $29 | $247 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
36 | $23 | $157 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
34 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
34 | $6 | $34 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
31 | $1 | $7 |
| Radiation therapy, 3+ areas, 6-10 MeV Radiation treatment delivered to three or more separate areas using advanced techniques like custom blocking and rotational beams with an energy level of 6-10 MeV. |
30 | $189 | $700 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
29 | $187 | $1,067 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $100 | $565 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
27 | $6 | $31 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
20 | $61 | $264 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $62 | $250 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
13 | $54 | $686 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
95.9% medium
3.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,494
Total received (2019-2024)
Avg $499/year across 5 years
Bottom 45% in TX for hematology & oncology
38
Companies
112
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,193 (87.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$301 (12.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,244
2023
$729
2022
$281
2020
$15
2019
$225
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$271
Novartis Pharmaceuticals Corporation
$208
AstraZeneca Pharmaceuticals LP
$159
Incyte Corporation
$158
Gilead Sciences, Inc.
$141
SOBI, INC
$137
Kyowa Kirin, Inc.
$125
Seattle Genetics, Inc.
$100
E.R. Squibb & Sons, L.L.C.
$93
Merck Sharp & Dohme LLC
$93
Daiichi Sankyo Inc.
$92
PharmaEssentia USA Corporation
$89
SANOFI-AVENTIS U.S. LLC
$85
Stemline Therapeutics Inc.
$81
GENZYME CORPORATION
$61
ABBVIE INC.
$60
PFIZER INC.
$57
Celgene Corporation
$54
Regeneron Healthcare Solutions, Inc.
$54
Janssen Biotech, Inc.
$44
Puma Biotechnology, Inc.
$33
Kite Pharma, Inc.
$29
Alexion Pharmaceuticals, Inc.
$26
Lilly USA, LLC
$23
Exelixis Inc.
$20
Eisai Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Sun Pharmaceutical Industries Inc.
$19
MorphoSys, US Inc.
$17
BeiGene USA, Inc.
$16
Rigel Pharmaceuticals, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Genentech USA, Inc.
$14
Mirati Therapeutics, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
Sirtex Medical Inc
$13
PUMA BIOTECHNOLOGY, INC.
$13
Astellas Pharma US Inc
$12
Top 3 companies account for 25.6% of total payments
Associated products mentioned in payments ›
ALUNBRIG · BESREMI · BLENREP · BRUKINSA · CABOMETYX · CALQUENCE · Doptelet · ELITEK · ENHERTU · EPKINLY · Enhertu · GAZYVA · GILOTRIF · IMFINZI · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · OJJAARA · OPDIVO · OXBRYTA · Odomzo · Orserdu · PIQRAY · PLUVICTO · POTELIGEO · PRECISETUMOR · REBLOZYL · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vanflyta · XTANDI · Xtandi · YERVOY · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
115
Per 100K population
4.4
County median income
$74,149
Nearest hospital
DALLAS REGIONAL MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Yin is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Yin experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Yin performed 9,000 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yin receive payments from pharmaceutical companies?
Yes. Dr. Yin received a total of $2,494 from 38 companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yin's costs compare to other hematology & oncology specialists in Mesquite?
Dr. Yin's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Mesquite
Browse hematology & oncology specialists in Mesquite ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology